About a third of young people who had sudden cardiac death used cocaine, heroin, or another illicit drug, often more than one such drug, in a registry study.
In a phase 1 study, a single dose of psilocybin with psychological support was safe and well-tolerated, and it decreased eating-disorder behaviors in some women with anorexia nervosa.
Subcutaneous ketamine is a practical, safe, and highly effective way to administer the drug for treatment-resistant depression, results of a randomized controlled phase 3 trial show.